High levels of high-sensitivity C reactive protein to albumin ratio can increase the risk of cardiovascular disease

Background The high levels of C reactive protein (CRP) to albumin ratio (CAR) is thought to increase the risk of poor outcomes for cancer and cardiovascular disease (CVD). However, the association between CAR and CVD in the Chinese community population has not been investigated. Objective The aim of this study was to investigate the association between CAR and CVD in the Chinese community population. Methods A total of 62 067 participants without a history of CVD or cancer were included in this study. Kaplan-Meier survival curves were used to calculate the cumulative incidence of endpoint events in CAR quartile groups, and the results were tested by log-rank test. Fine-Gray model was used to analyse the competing risk of death. C-index, Net Reclassification Index (NRI) and Integrated Discrimination Improvement Index (IDI) of different indicators were calculated to distinguish the predictive performance of different indicators. Results During an average follow-up period of 10.3±2.1 years, 4025 participants developed CVD. In multivariable Cox regression analysis, compared with Q1 group, model 3 showed that the hazard ratio (HR) (95% confidence interval (95%CI)) of CVD in Q4 group was 1.26 (1.15 to 1.38) (p<0.01), and the HR (95% CI) per 1 SD increase was 1.06 (1.03 to 1.08) (p<0.01). The C-index, continuous NRI and IDI for predicting 10-year CVD were 73.48%, 0.1366 (0.1049 to 0.1684) (p<0.01) and 0.0002 (0.0001 to 0.0004) (p<0.01), respectively, which were higher than those of hs-CRP (C-index:0.7344, NRI:0.0711, IDI: 0.0001) and albumin (C-index:0.7339, NRI: −0.0090, IDI: 0.0000). Conclusion High levels of CAR can increase the risk of CVD and the predictive performance of CAR for CVD is better than that of hs-CRP or albumin alone.

[1]  M. Ezzati,et al.  Prevalence, awareness, treatment, and control of hypertension in China, 2004-18: findings from six rounds of a national survey , 2023, BMJ.

[2]  Tiewei Li,et al.  C-Reactive Protein-to-Albumin Ratio as an Early Biomarker to Identify Sepsis in Neonates with Pneumonia , 2022, Mediators of inflammation.

[3]  Jing Wang,et al.  The Association Between High-Sensitivity C-Reactive Protein/Albumin Ratio and Cardiovascular Prognosis in Patients Undergoing Percutaneous Coronary Intervention , 2022, Angiology.

[4]  A. Manolis,et al.  Low serum albumin: A neglected predictor in patients with cardiovascular disease. , 2022, European journal of internal medicine.

[5]  L. Conradi,et al.  C-Reactive Protein to Albumin Ratio in Patients Undergoing Transcatheter Aortic Valve Replacement. , 2022, Mayo Clinic proceedings.

[6]  E. Mascha,et al.  Aggressive intraoperative warming versus routine thermal management during non-cardiac surgery (PROTECT): a multicentre, parallel group, superiority trial , 2022, The Lancet.

[7]  S. Mathoulin-Pélissier,et al.  Prognostic Value of Routinely Measured Inflammatory Biomarkers in Older Cancer Patients: Pooled Analysis of Three Cohorts , 2021, Cancers.

[8]  Zuyi Yuan,et al.  The Usefulness of C-Reactive Protein to Albumin Ratio in the Prediction of Adverse Cardiovascular Events in Coronary Chronic Total Occlusion Undergoing Percutaneous Coronary Intervention , 2021, Frontiers in Cardiovascular Medicine.

[9]  Jilin Li,et al.  Prognostic Value of C-Reactive Protein, Glasgow Prognostic Score, and C-Reactive Protein-to-Albumin Ratio in Colorectal Cancer , 2021, Frontiers in Cell and Developmental Biology.

[10]  M. Can,et al.  Prognostic value of the C-reactive protein to albumin ratio in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. , 2021, Turkish journal of medical sciences.

[11]  H. Acet,et al.  Predictive Value of C-Reactive Protein to Albumin Ratio in ST-Segment Elevation Myocardial Infarction Patients Treated With Primary Percutaneous Coronary Intervention , 2020, Angiology.

[12]  F. Aksoy,et al.  Relationship between c-reactive protein/albumin ratio and new-onset atrial fibrillation after coronary artery bypass grafting. , 2020, Revista da Associacao Medica Brasileira.

[13]  H. Noels,et al.  Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting. , 2020, Advanced drug delivery reviews.

[14]  B. Nordestgaard,et al.  Plasma Albumin and Incident Cardiovascular Disease , 2019, Arteriosclerosis, thrombosis, and vascular biology.

[15]  Heng-Chen Yao,et al.  High sensitivity C-reactive protein to prealbumin ratio measurement as a marker of the prognosis in acute coronary syndrome , 2019, Scientific Reports.

[16]  Mayra Gonçalves Menegheti The use of APACHE II, SOFA, SAPS 3, C-reactive protein/albumin ratio, and lactate to predict mortality of surgical critically ill patients: A retrospective cohort study: Erratum , 2019, Medicine.

[17]  T. Oh,et al.  Clinical usefulness of C-reactive protein to albumin ratio in predicting 30-day mortality in critically ill patients: A retrospective analysis , 2018, Scientific Reports.

[18]  E. Y. Kim,et al.  The C-Reactive Protein/Albumin Ratio as a Predictor of Mortality in Critically Ill Patients , 2018, Journal of clinical medicine.

[19]  L. Gürke,et al.  Letter by Tampaki et al Regarding Article, "Cardiovascular Effects of New Oral Glucose-Lowering Agents: DPP-4 and SGLT-2 Inhibitors". , 2018, Circulation research.

[20]  Yanmei Xu,et al.  Two new inflammatory markers associated with disease activity score‐28 in patients with rheumatoid arthritis: Albumin to fibrinogen ratio and C‐reactive protein to albumin ratio , 2018, International immunopharmacology.

[21]  S. Arques Human serum albumin in cardiovascular diseases. , 2018, European journal of internal medicine.

[22]  S. Anderson,et al.  Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis , 2016, The Lancet.

[23]  Y. Iwasaki,et al.  Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal Cancer , 2016, Annals of Surgical Oncology.

[24]  K. Sung,et al.  C-reactive protein and risk of cardiovascular and all-cause mortality in 268 803 East Asians. , 2014, European heart journal.

[25]  Michael J Blaha,et al.  High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link? , 2013, Journal of the American College of Cardiology.

[26]  Marcelo Park,et al.  C-Reactive Protein/Albumin Ratio Predicts 90-Day Mortality of Septic Patients , 2013, PloS one.

[27]  J. Gallacher,et al.  C-reactive protein, fibrinogen, and cardiovascular disease prediction. , 2012, The New England journal of medicine.

[28]  Kuibao Li,et al.  Prevalence of Ideal Cardiovascular Health and Its Relationship With the 4-Year Cardiovascular Events in a Northern Chinese Industrial City , 2012, Circulation. Cardiovascular quality and outcomes.

[29]  Chong Shen,et al.  Intra-individual variability of high-sensitivity C-reactive protein in Chinese general population. , 2012, International journal of cardiology.

[30]  J. Danesh,et al.  C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis , 2010, The Lancet.

[31]  R. Marshall,et al.  Waist circumference, body mass index and waist to hip ratio for prediction of the metabolic syndrome in Chinese. , 2009, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[32]  Q. Ou,et al.  Correlation between albumin to fibrinogen ratio, C-reactive protein to albumin ratio and Th17 cells in patients with rheumatoid arthritis. , 2019, Clinica chimica acta; international journal of clinical chemistry.